Last Updated 20 May 2022.
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
Approval Source: anp.ne
Non Replicating Viral Vector
Approved in 91 countries
29 trials in 12 countries
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form